©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Virol. Sep 25, 2022; 11(5): 293-299
Published online Sep 25, 2022. doi: 10.5501/wjv.v11.i5.293
Published online Sep 25, 2022. doi: 10.5501/wjv.v11.i5.293
Rhino-orbital-cerebral mucormycosis as a complication of coronavirus disease 2019
Raid M Al-Ani, Department of Surgery/Otolaryngology, University of Anbar, College of Medicine, Ramadi 31001, Anbar, Iraq
Author contributions: Raid M Al-Ani performed all aspects of this manuscript’s generation.
Conflict-of-interest statement: The author declares that there is no conflict of interest.
Corresponding author: Raid M Al-Ani, MBChB, Academic Research, Full Professor, Senior Editor, Surgeon, Department of Surgery/Otolaryngology, University of Anbar, College of Medicine, Al-Thaela, Ramadi 31001, Anbar, Iraq. med.raed.alani2003@uoanbar.edu.iq
Received: April 17, 2022
Peer-review started: April 17, 2022
First decision: May 12, 2022
Revised: May 13, 2022
Accepted: August 12, 2022
Article in press: August 12, 2022
Published online: September 25, 2022
Processing time: 159 Days and 12.1 Hours
Peer-review started: April 17, 2022
First decision: May 12, 2022
Revised: May 13, 2022
Accepted: August 12, 2022
Article in press: August 12, 2022
Published online: September 25, 2022
Processing time: 159 Days and 12.1 Hours
Core Tip
Core Tip: Rhino-orbital-cerebral mucormycosis is an aggressive, opportunistic fungal infection. There is an increment in cases of this condition in the era of coronavirus disease 2019, particularly in India. It usually affects the severe or critical types of the COVID-19 and those with a history of diabetes mellitus, corticosteroid therapy, and mechanical ventilation. Early diagnosis with prompt treatment carries a better outcome. The treatment consists of intravenous or local amphotericin B, surgical debridement, and reversal of any immunocompromised conditions. However, this disease has a poor prognosis with a high rate of morbidity and mortality.